Tag: urgent safety measure

Unblinding for Safety Reasons: Minimal-Disclosure Paths That Protect Participants and Preserve Trial Integrity (2025)

November 3, 2025 digi

Unblinding for Safety Reasons: Minimal-Disclosure Paths That Protect Participants and Preserve Trial Integrity (2025) Unblinding for Safety: How to Protect Participants Without Breaking Your Trial Purpose, Principles, and the Global Compliance Frame Unblinding is the controlled disclosure of a participant’s treatment allocation when knowledge of the code is necessary to protect safety or to interpret…

Adverse Event Reporting & SAE Management, Unblinding for Safety Reasons

Communication with IRB/Regulators: A Regulator-Ready System for Fast, Clear, and Defensible Safety Notices (2025)

November 3, 2025 digi

Communication with IRB/Regulators: A Regulator-Ready System for Fast, Clear, and Defensible Safety Notices (2025) Building Inspection-Ready Communications with IRBs and Regulators During Safety Events Purpose, Principles, and the Global Ethics–Regulatory Frame Clear, timely communication with Institutional Review Boards/Independent Ethics Committees (IRBs/IECs) and health authorities is the fulcrum of credible safety management. The aim is not…

Adverse Event Reporting & SAE Management, Communication with IRB/Regulators

Deviation & Incident Management in Clinical Trials: Fast Containment, Clear Decisions, and Audit-Ready Evidence

October 31, 2025 digi

Deviation & Incident Management in Clinical Trials: Fast Containment, Clear Decisions, and Audit-Ready Evidence Managing Deviations and Incidents: A Practical, Inspectable System for Clinical Programs Defining Deviations & Incidents: Taxonomy, Thresholds, and Regulatory Context Deviation and incident management is the clinical QMS mechanism that detects departures from protocol, SOPs, or regulations, protects participants, and preserves…

Clinical Quality Management & CAPA, Deviation/Incident Management